Hemp Therapies Wiki / Cannabinoids & Plant Chemistry

CBN (Cannabinol)

CBN, short for cannabinol, is a cannabinoid that forms mainly as a degradation product of THC rather than being produced directly by the plant in meaningful quantities.

How CBN Forms

As cannabis ages, THC slowly transforms into CBN through oxidation — exposure to heat, sunlight, or time converts one compound into the other. Newly harvested cannabis or hemp contains very little CBN, since this conversion takes time to occur. Light and heat exposure speed up the process, which is one reason cannabinoid products are commonly stored in cool, dark conditions. Under typical storage conditions, THC has been reported to degrade at roughly 0.1–0.5% per month; in one illustrative example, a sample starting at 20% THC and stored in a clear glass container for six months showed THC content falling to about 12% while CBN content rose to about 4%.

CBN’s Receptor Activity Compared to THC

Delta-9 THC’s reported binding affinity at the CB1 receptor is approximately 21 nM, roughly ten times stronger than CBN’s reported CB1 binding affinity of approximately 211 nM. Laboratory research describes CBN as a partial CB1 agonist, around ten times less potent than THC at that receptor. CBN’s reported CB2 binding affinity, approximately 126 nM, is stronger than its CB1 binding affinity. Pure CBN binds CB1 receptors comparatively weakly; its metabolized form, 11-hydroxycannabinol, binds more readily to CB1, which researchers have offered as a possible explanation for why pure CBN’s effects may take longer to appear than THC’s.

The Current State of CBN and Sleep Research

Clinical research on CBN and sleep has been described as still limited, with insufficient data to form a complete picture of its pharmacology. One review identified nine peer-reviewed, placebo-controlled or blinded human studies involving CBN, most of which were not focused on sleep specifically — only two of the nine showed any indication of sleep-related effects. Animal studies on CBN and sleep have produced inconsistent results across different research groups.

A 2024 polysomnography study — using objective brain-wave and sleep-cycle measurement rather than self-report — was described as the first to examine CBN’s effects on sleep architecture this way in an animal model. In that study, CBN increased total sleep time in the animal model by an amount comparable in magnitude to a standard dose of the prescription sleep medication zolpidem, but unlike zolpidem, CBN did not suppress REM sleep. The study also reported increased deep-sleep duration, fewer deep-sleep interruptions, and increased REM sleep during later sleep cycles. Effects were reported as modest on the first day of dosing and grew over the following two weeks of continued dosing, with no adverse effects observed at the doses tested. Human trial data on CBN specifically remains limited; most mechanistic and sleep-architecture research to date uses animal models.

Studied CBN, CBD, and THC Combinations

Combination formulations have been studied more than CBN alone. In a randomized, double-blind, crossover study of 23 patients with chronic insomnia disorder, an oral formulation combining THC (20 mg/mL), CBN (2 mg/mL), and CBD (1 mg/mL) was administered over two weeks; participants using the formulation self-reported lower Insomnia Severity Index scores and improvements in sleep quality and duration compared with placebo. One studied formulation, referred to in research literature as ZTL-101, used a THC:CBN:CBD ratio of 20:2:1, tested at 10 mg THC plus 1 mg CBN plus 0.5 mg CBD, with an optional doubled dose. A separate study tested 20 mg THC combined with 40 mg CBN administered orally, compared against placebo.

Summary

CBN is not a cannabinoid the plant produces directly in quantity — it accumulates as THC degrades with age, heat, and light exposure. Its receptor activity resembles a weaker version of THC’s at CB1, and research into CBN specifically, as opposed to combination formulations with THC and CBD, remains limited and mostly confined to animal studies.